NØRAGER BIO- & MILJØANLÆG A.M.B.A

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2016
2016/7
2017
2017/7
2018
2018/7
2019
2019/7
2020
2020/7
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  13.6% 17.5% 8.3% 7.1% 14.9%  
Credit score (0-100)  19 10 31 35 14  
Credit rating  BB B BB BBB BB  
Credit limit (kDKK)  -0.0 -0.0 -0.0 -0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2016
2016/7
2017
2017/7
2018
2018/7
2019
2019/7
2020
2020/7

Net sales  0 0 0 0 0  
Gross profit  -7.7 -9.6 -6.1 -7.5 42.4  
EBITDA  -7.7 -9.6 -6.1 -7.5 42.4  
EBIT  -114 -444 -6.1 -7.5 -50.1  
Pre-tax profit (PTP)  -141.6 -481.7 -46.2 -49.6 -93.9  
Net earnings  -141.6 -481.7 -46.2 -49.6 -93.9  
Pre-tax profit without non-rec. items  -142 -482 -46.2 -49.6 -93.9  

 
See the entire income statement

Balance sheet (kDKK) 
2016
2016/7
2017
2017/7
2018
2018/7
2019
2019/7
2020
2020/7

Tangible assets total  107 97.5 97.5 97.5 5.0  
Shareholders equity total  -402 -884 -930 -980 -1,073  
Interest-bearing liabilities  0.0 976 0.1 0.0 0.0  
Balance sheet total (assets)  533 99.2 97.6 103 59.9  

Net Debt  -1.8 975 0.1 -5.4 -44.1  
 
See the entire balance sheet

Volume 
2016
2016/7
2017
2017/7
2018
2018/7
2019
2019/7
2020
2020/7

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -7.7 -9.6 -6.1 -7.5 42.4  
Gross profit growth  0.0% -24.6% 36.2% -23.5% 0.0%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  533 99 98 103 60  
Balance sheet change%  0.0% -81.4% -1.6% 5.4% -41.8%  
Added value  -7.7 -9.6 -6.1 -7.5 42.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  425 -868 0 0 -185  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 -2.0 -3.0 -4.0 -5.0  

Profitability 
2016
2016/7
2017
2017/7
2018
2018/7
2019
2019/7
2020
2020/7
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  1,489.4% 4,642.9% 100.0% 100.0% -118.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -12.2% -46.2% -0.6% -0.7% -4.5%  
ROI %  0.0% -90.8% -1.2% -13,205.3% 0.0%  
ROE %  -26.6% -152.3% -47.0% -49.5% -115.4%  

Solidity 
2016
2016/7
2017
2017/7
2018
2018/7
2019
2019/7
2020
2020/7
Equity ratio %  -43.0% -89.9% -90.5% -90.5% -94.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  23.3% -10,210.8% -1.9% 71.6% -103.9%  
Gearing %  0.0% -110.5% -0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 7.8% 8.2% 74,456.6% 0.0%  

Liquidity 
2016
2016/7
2017
2017/7
2018
2018/7
2019
2019/7
2020
2020/7
Quick Ratio  0.0 0.0 0.0 0.0 0.0  
Current Ratio  0.0 0.0 0.0 0.0 0.0  
Cash and cash equivalent  1.8 1.1 0.0 5.4 44.1  

Capital use efficiency 
2016
2016/7
2017
2017/7
2018
2018/7
2019
2019/7
2020
2020/7
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -933.5 -981.2 -1,027.5 -1,077.0 -1,078.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2016
2016/7
2017
2017/7
2018
2018/7
2019
2019/7
2020
2020/7
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0